These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 944644)

  • 1. Effect of 6-hydroxydopamine pretreatment on spontaneous convulsions induced by barbital withdrawal.
    Morgan WW
    Experientia; 1976 Apr; 32(4):489-91. PubMed ID: 944644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-methyl-p-tyrosine on the incidence of spontaneous convulsions observed following barbital withdrawal.
    Morgan WW; Pfeil KA; Gonzales EG
    Neuropharmacology; 1978 Feb; 17(2):115-9. PubMed ID: 565016
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats.
    McCaslin PP; Morgan WW
    Neuropharmacology; 1987 Jul; 26(7A):731-5. PubMed ID: 2819762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.
    Morgan WW; Pfeil KA; Gonzales EG
    Life Sci; 1977 Feb; 20(3):493-9. PubMed ID: 557159
    [No Abstract]   [Full Text] [Related]  

  • 5. The interaction between spontaneous convulsions and tolerance to hexobarbital in the abstinence after chronic barbital treatments in the rat.
    Wahlström G
    Life Sci; 1976 Dec; 19(12):1817-26. PubMed ID: 1034185
    [No Abstract]   [Full Text] [Related]  

  • 6. Central nervous system supersensitivity and withdrawal from long-term treatment with barbital.
    Sandoval MR; Palermo-Neto J
    Neuropharmacology; 1985 Dec; 24(12):1247-51. PubMed ID: 4094660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic influences on barbital withdrawal induced convulsions.
    Sandoval MR; Palermo-Neto J
    Gen Pharmacol; 1986; 17(4):431-5. PubMed ID: 3758649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of synthesis inhibition on the levels of brain catecholamines in barbital-dependent rats.
    Morgan WW; Huffman RD; Pfeil KA; Gonzales EG
    Psychopharmacology (Berl); 1978 Jan; 56(1):41-4. PubMed ID: 415325
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticonvulsive activity of several excitatory amino acid antagonists against barbital withdrawal-induced spontaneous convulsions.
    McCaslin PP; Morgan WW
    Eur J Pharmacol; 1988 Mar; 147(3):381-6. PubMed ID: 3378564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convulsive seizures following barbiturate withdrawal.
    OSGOOD CW
    J Am Med Assoc; 1947 Jan; 133(2):104. PubMed ID: 20278620
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on interactions between striatal dopaminergic and cholinergic mechanisms in the early abstinence after chronic treatment with barbital in the rat.
    Persson SA; Wahlström G
    Subst Alcohol Actions Misuse; 1984; 5(3):149-57. PubMed ID: 6438820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical dependence produced by long duration, low dose chronic barbital treatment.
    Okamoto M; Hinman DJ
    Subst Alcohol Actions Misuse; 1984; 5(2):97-103. PubMed ID: 6540898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of propranolol on barbital dependence formation and withdrawal signs.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1983 Feb; 33(1):133-43. PubMed ID: 6683767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of alcohol withdrawal seizures with 6-hydroxydopamine.
    Chu NS
    Epilepsia; 1978 Dec; 19(6):603-9. PubMed ID: 216544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sex differences in the physical dependence on barbital in rats].
    Suzuki T; Koike Y; Yoshii T; Yanaura S
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):373-80. PubMed ID: 3825311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
    Tagashira E; Hiramori T; Nakao K; Urano T; Yanaura S
    Life Sci; 1983 Apr; 32(14):1599-606. PubMed ID: 6682167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased response of cerebellar cGMP to kainate but not NMDA or quisqualate following barbital withdrawal from dependent rats.
    McCaslin PP; Morgan WW
    Eur J Pharmacol; 1989 Dec; 173(2-3):127-32. PubMed ID: 2560429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility of audiogenic rats to barbital withdrawal convulsions.
    Bourn WM; Garrett RL
    Pharmacol Biochem Behav; 1983 Nov; 19(5):839-41. PubMed ID: 6685882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in brain levels of cyclic nucleotides and gamma-aminobutyric acid in barbiturate dependence and withdrawal.
    Lenox RH; Wray HL; Kant GJ; Hawkins TD; Meyerhoff JL
    Eur J Pharmacol; 1979 Apr; 55(2):159-69. PubMed ID: 222596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific action of tranylcypromine to precipitate barbital withdrawal convulsions.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S; Kuroiwa Y
    Psychopharmacology (Berl); 1982; 77(2):101-4. PubMed ID: 6812126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.